Report Detail

Pharma & Healthcare Global Acromegaly Market Insights, Forecast to 2025

  • RnM2451709
  • |
  • 22 May, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly.
The global Acromegaly market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acromegaly market based on company, product type, end user and key regions.

This report studies the global market size of Acromegaly in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acromegaly in these regions.
This research report categorizes the global Acromegaly market by top players/brands, region, type and end user. This report also studies the global Acromegaly market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
IPSEN
Pfizer

Market size by Product
Octreotide
Pasireotide
Lanreotide
Pegvisomant
Market size by End User
Hospital
Pharmacy

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Acromegaly market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Acromegaly market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Acromegaly companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Acromegaly submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Acromegaly are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acromegaly market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Acromegaly Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Acromegaly Market Size Growth Rate by Product
      • 1.4.2 Octreotide
      • 1.4.3 Pasireotide
      • 1.4.4 Lanreotide
      • 1.4.5 Pegvisomant
    • 1.5 Market by End User
      • 1.5.1 Global Acromegaly Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Pharmacy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Acromegaly Market Size
      • 2.1.1 Global Acromegaly Revenue 2014-2025
      • 2.1.2 Global Acromegaly Sales 2014-2025
    • 2.2 Acromegaly Growth Rate by Regions
      • 2.2.1 Global Acromegaly Sales by Regions
      • 2.2.2 Global Acromegaly Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Acromegaly Sales by Manufacturers
      • 3.1.1 Acromegaly Sales by Manufacturers
      • 3.1.2 Acromegaly Sales Market Share by Manufacturers
      • 3.1.3 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
    • 3.2 Acromegaly Revenue by Manufacturers
      • 3.2.1 Acromegaly Revenue by Manufacturers (2014-2019)
      • 3.2.2 Acromegaly Revenue Share by Manufacturers (2014-2019)
    • 3.3 Acromegaly Price by Manufacturers
    • 3.4 Acromegaly Manufacturing Base Distribution, Product Types
      • 3.4.1 Acromegaly Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Acromegaly Product Type
      • 3.4.3 Date of International Manufacturers Enter into Acromegaly Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Acromegaly Sales by Product
    • 4.2 Global Acromegaly Revenue by Product
    • 4.3 Acromegaly Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Acromegaly Breakdown Data by End User

    6 North America

    • 6.1 North America Acromegaly by Countries
      • 6.1.1 North America Acromegaly Sales by Countries
      • 6.1.2 North America Acromegaly Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Acromegaly by Product
    • 6.3 North America Acromegaly by End User

    7 Europe

    • 7.1 Europe Acromegaly by Countries
      • 7.1.1 Europe Acromegaly Sales by Countries
      • 7.1.2 Europe Acromegaly Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Acromegaly by Product
    • 7.3 Europe Acromegaly by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Acromegaly by Countries
      • 8.1.1 Asia Pacific Acromegaly Sales by Countries
      • 8.1.2 Asia Pacific Acromegaly Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Acromegaly by Product
    • 8.3 Asia Pacific Acromegaly by End User

    9 Central & South America

    • 9.1 Central & South America Acromegaly by Countries
      • 9.1.1 Central & South America Acromegaly Sales by Countries
      • 9.1.2 Central & South America Acromegaly Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Acromegaly by Product
    • 9.3 Central & South America Acromegaly by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Acromegaly by Countries
      • 10.1.1 Middle East and Africa Acromegaly Sales by Countries
      • 10.1.2 Middle East and Africa Acromegaly Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Acromegaly by Product
    • 10.3 Middle East and Africa Acromegaly by End User

    11 Company Profiles

    • 11.1 Novartis
      • 11.1.1 Novartis Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis Acromegaly Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis Acromegaly Products Offered
      • 11.1.5 Novartis Recent Development
    • 11.2 IPSEN
      • 11.2.1 IPSEN Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 IPSEN Acromegaly Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 IPSEN Acromegaly Products Offered
      • 11.2.5 IPSEN Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Acromegaly Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Acromegaly Products Offered
      • 11.3.5 Pfizer Recent Development

    12 Future Forecast

    • 12.1 Acromegaly Market Forecast by Regions
      • 12.1.1 Global Acromegaly Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Acromegaly Revenue Forecast by Regions 2019-2025
    • 12.2 Acromegaly Market Forecast by Product
      • 12.2.1 Global Acromegaly Sales Forecast by Product 2019-2025
      • 12.2.2 Global Acromegaly Revenue Forecast by Product 2019-2025
    • 12.3 Acromegaly Market Forecast by End User
    • 12.4 North America Acromegaly Forecast
    • 12.5 Europe Acromegaly Forecast
    • 12.6 Asia Pacific Acromegaly Forecast
    • 12.7 Central & South America Acromegaly Forecast
    • 12.8 Middle East and Africa Acromegaly Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Acromegaly Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Acromegaly . Industry analysis & Market Report on Acromegaly is a syndicated market report, published as Global Acromegaly Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Acromegaly market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report